NEW YORK, Oct. 9, 2018 /PRNewswire/ -- HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the successful first closing at $100 Million of its fourth fund. The Musculoskeletal Fund IV will continue HealthpointCapital's successful strategy of investing in differentiated technology and service companies in the orthopedics, spine, dental, maxillofacial, rehabilitation and digital health sectors. The Fund's target size is $500 Million, with the intention to invest in eight to ten innovative growth-stage companies that can benefit from HealthpointCapital's sector focus, industry / management experience, and investment.
Commenting on the announcement, Mike Mogul, HealthpointCapital's President, said: "The first closing for Fund IV represents a milestone and a validation of our strategy. Musculoskeletal healthcare offers attractive opportunities that require not only capital, but also operational expertise and strong healthcare professional and commercial relationships."
"Healthcare is rapidly evolving, and we will continue to focus on innovation that addresses both patient outcomes and care costs," said John Foster, CEO and Founder of HealthpointCapital. "We are grateful for our investors' support and are actively sourcing new investments for the fund."
Notable recent exits for HealthpointCapital include Blue Belt Technologies, Inc. (acquired by Smith & Nephew plc) and BioHorizons, Inc. (acquired by Henry Schein, Inc.).
Founded in 2002, HealthpointCapital is the leading private equity firm focused exclusively on the musculoskeletal sector. The Firm is led by CEO and founder John H. Foster and Mike Mogul, former Group President, Orthopaedics at Stryker Corporation and former CEO of DJO Global. HealthpointCapital brings together extensive medical technology operating experience, strong private equity track record and a deep network of relationships to help portfolio companies accelerate growth.
For additional information, visit www.healthpointcapital.com.
For investor or media inquiries, please contact:
Tessa Cicitta, HealthpointCapital, 212-935-7780 or [email protected]